Prediction of Other-Cause Mortality in Older Patients with Breast Cancer Using Comorbidity

Anna Z de Boer1,2, Esther Bastiaannet1,2, Hein Putter3

  • 1Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

Cancers
|April 30, 2021
PubMed

Insights

A simple comorbidity count is as effective as the Charlson comorbidity index for predicting other-cause mortality in older breast cancer patients. This finding supports using comorbidity count for personalized treatment strategies in this demographic.

Area of Science:

  • Oncology
  • Geriatrics
  • Epidemiology

Background:

  • Individualized treatment for older breast cancer patients requires accurate prediction of other-cause mortality.
  • Existing prediction tools may not optimally incorporate comorbidity data, which is crucial given age-related mortality risks.
  • No definitive comorbidity scoring system is established for this specific purpose.

Purpose of the Study:

  • To compare the predictive performance of the Charlson comorbidity index against a simple comorbidity count for 5-year other-cause mortality in older breast cancer patients.
  • To evaluate the impact of specific, frequently occurring comorbidities on other-cause mortality.
  • To assess the utility of these measures in improving individualized treatment strategies.

Main Methods:

  • Retrospective cohort study using the Netherlands Cancer Registry.
  • Inclusion of surgically treated patients aged ≥70 years with stages I-III breast cancer (2003-2009).
  • Competing risk analysis to evaluate the association between comorbidities (Charlson index, comorbidity count, specific conditions) and 5-year other-cause mortality, including discrimination and calibration assessment.

Main Results:

  • 7511 patients were analyzed; 26% died from other causes within 5 years.
  • The Charlson comorbidity index and simple comorbidity count demonstrated similar predictive values (c-statistics: 0.65 and 0.64, respectively).
  • Psychiatric disease showed a strong association with other-cause mortality (sHR 2.44), independent of the Charlson index components.

Conclusions:

  • The Charlson comorbidity index and a simple comorbidity count have comparable predictive value for 5-year other-cause mortality in older breast cancer patients.
  • Comorbidity count offers a more practical tool for clinical use, potentially aiding in the individualization of treatment.
  • Further research incorporating geriatric parameters may enhance prediction accuracy.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
497
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
376
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
348
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
175
Nursing Diagnosis01:22

Nursing Diagnosis

Following assessment, a nursing diagnosis is the next step in the nursing process. It begins after the nurse has collected and recorded the patient data. The purpose of diagnosing is to identify how the client responds to actual or potential health processes, identify factors that bestow or that cause health problems, the etiologies, and identify resources or strengths the individual, group, or community can draw on to prevent or resolve problems.
The nursing diagnosis focuses on evidence-based...
3.4K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
232